Ridgetech Inc. has announced the appointment of Lingtao Kong as its new Chief Executive Officer, effective November 1, 2026. This change comes as the company seeks to enhance its leadership structure within the competitive retail drug store sector.

Kong, who is also the Chair of the Board, will continue to lead the company while overseeing its strategic direction and operations. His appointment replaces Ming Zhao, who served as the Interim CEO and will now focus solely on his role as Chief Financial Officer.

This leadership transition is significant for Ridgetech, as it aims to strengthen its market position and operational efficiency. With Kong at the helm, the company is expected to pursue new strategies to navigate the challenges and opportunities in the retail drug store industry.

Background

Ridgetech Inc. operates in the retail-drug stores and proprietary stores sector, classified under SIC code 5912. The company is publicly traded on the Nasdaq under the ticker RDGT. Ridgetech, formerly known as China Jo-Jo Drugstores, Inc., has undergone several name changes in recent years, reflecting its evolving business strategy.

What the Filing Says

According to the recent SEC filing, the Board of Directors approved Kong's appointment on November 5, 2026. The filing states, "Mr. Kong will continue serving as Chair of the Board" and mentions that Zhao will remain with the company as CFO.

Impact

This appointment may affect various stakeholders, including employees, investors, and customers. As Kong steps into the CEO role, his leadership style and strategic decisions will likely influence company performance and shareholder confidence. Additionally, the retail-drug store sector may see shifts in competitive dynamics as Ridgetech implements new strategies under Kong's leadership.

What's Next

The filing does not specify what happens next, but industry observers will be keen to see how Kong's leadership impacts Ridgetech's strategic initiatives moving forward.